25149184|t|Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin.
25149184|a|BACKGROUND: We recently found that brain tissue from patients with type-2 diabetes (T2D) and cognitive impairment contains deposits of amylin, an amyloidogenic hormone synthesized and co-secreted with insulin by pancreatic beta-cells. Amylin deposition is promoted by chronic hypersecretion of amylin (hyperamylinemia), which is common in humans with obesity or pre-diabetic insulin resistance. Human amylin oligomerizes quickly when oversecreted, which is toxic, induces inflammation in pancreatic islets and contributes to the development of T2D. Here, we tested the hypothesis that accumulation of oligomerized amylin affects brain function. METHODS: In contrast to amylin from humans, rodent amylin is neither amyloidogenic nor cytotoxic. We exploited this fact by comparing rats overexpressing human amylin in the pancreas (HIP rats) with their littermate rats which express only wild-type (WT) non-amyloidogenic rodent amylin. Cage activity, rotarod and novel object recognition tests were performed on animals nine months of age or older. Amylin deposition in the brain was documented by immunohistochemistry, and western blot. We also measured neuroinflammation by immunohistochemistry, quantitative real-time PCR and cytokine protein levels. RESULTS: Compared to WT rats, HIP rats show i) reduced exploratory drive, ii) impaired recognition memory and iii) no ability to improve the performance on the rotarod. The development of neurological deficits is associated with amylin accumulation in the brain. The level of oligomerized amylin in supernatant fractions and pellets from brain homogenates is almost double in HIP rats compared with WT littermates (P < 0.05). Large amylin deposits (>50 mum diameter) were also occasionally seen in HIP rat brains. Accumulation of oligomerized amylin alters the brain structure at the molecular level. Immunohistochemistry analysis with an ED1 antibody indicates possible activated microglia/macrophages which are clustering in areas positive for amylin infiltration. Multiple inflammatory markers are expressed in HIP rat brains as opposed to WT rats, confirming that amylin deposition in the brain induces a neuroinflammatory response. CONCLUSIONS: Hyperamylinemia promotes accumulation of oligomerized amylin in the brain leading to neurological deficits through an oligomerized amylin-mediated inflammatory response. Additional studies are needed to determine whether brain amylin accumulation may predispose to diabetic brain injury and cognitive decline.
25149184	0	17	Neuroinflammation	Disease	MESH:D000090862
25149184	22	41	neurologic deficits	Disease	MESH:D009461
25149184	45	53	diabetes	Disease	MESH:D003920
25149184	86	92	amylin	Gene	3375
25149184	147	155	patients	Species	9606
25149184	161	176	type-2 diabetes	Disease	MESH:D003924
25149184	178	181	T2D	Disease	MESH:D003924
25149184	187	207	cognitive impairment	Disease	MESH:D003072
25149184	229	235	amylin	Gene	3375
25149184	240	253	amyloidogenic	Disease	
25149184	295	302	insulin	Gene	3630
25149184	329	335	Amylin	Gene	24476
25149184	388	394	amylin	Gene	3375
25149184	396	411	hyperamylinemia	Disease	
25149184	433	439	humans	Species	9606
25149184	445	452	obesity	Disease	MESH:D009765
25149184	456	487	pre-diabetic insulin resistance	Disease	MESH:D007333
25149184	489	494	Human	Species	9606
25149184	495	501	amylin	Gene	3375
25149184	566	578	inflammation	Disease	MESH:D007249
25149184	638	642	T2D.	Disease	MESH:D003924
25149184	708	714	amylin	Gene	3375
25149184	763	769	amylin	Gene	3375
25149184	775	781	humans	Species	9606
25149184	783	789	rodent	Species	9989
25149184	790	796	amylin	Gene	3375
25149184	808	821	amyloidogenic	Disease	
25149184	826	835	cytotoxic	Disease	MESH:D064420
25149184	873	877	rats	Species	10116
25149184	893	898	human	Species	9606
25149184	899	905	amylin	Gene	3375
25149184	923	926	HIP	Disease	OMIM:142700
25149184	927	931	rats	Species	10116
25149184	955	959	rats	Species	10116
25149184	998	1011	amyloidogenic	Disease	
25149184	1012	1018	rodent	Species	9989
25149184	1019	1025	amylin	Gene	3375
25149184	1140	1146	Amylin	Gene	24476
25149184	1246	1263	neuroinflammation	Disease	MESH:D000090862
25149184	1369	1373	rats	Species	10116
25149184	1375	1378	HIP	Disease	OMIM:142700
25149184	1379	1383	rats	Species	10116
25149184	1423	1450	impaired recognition memory	Disease	MESH:D008569
25149184	1533	1554	neurological deficits	Disease	MESH:D009461
25149184	1574	1580	amylin	Gene	24476
25149184	1634	1640	amylin	Gene	24476
25149184	1721	1724	HIP	Disease	OMIM:142700
25149184	1725	1729	rats	Species	10116
25149184	1777	1783	amylin	Gene	24476
25149184	1843	1846	HIP	Disease	OMIM:142700
25149184	1847	1850	rat	Species	10116
25149184	1888	1894	amylin	Gene	24476
25149184	2091	2097	amylin	Gene	24476
25149184	2121	2133	inflammatory	Disease	MESH:D007249
25149184	2159	2162	HIP	Disease	OMIM:142700
25149184	2163	2166	rat	Species	10116
25149184	2191	2195	rats	Species	10116
25149184	2213	2219	amylin	Gene	24476
25149184	2254	2271	neuroinflammatory	Disease	MESH:D000090862
25149184	2295	2310	Hyperamylinemia	Disease	
25149184	2349	2355	amylin	Gene	24476
25149184	2380	2401	neurological deficits	Disease	MESH:D009461
25149184	2426	2432	amylin	Gene	24476
25149184	2442	2454	inflammatory	Disease	MESH:D007249
25149184	2522	2528	amylin	Gene	24476
25149184	2560	2581	diabetic brain injury	Disease	MESH:D001930
25149184	2586	2603	cognitive decline	Disease	MESH:D003072
25149184	Association	MESH:D003920	3375
25149184	Positive_Correlation	MESH:D008569	24476
25149184	Association	MESH:D007249	3375
25149184	Association	MESH:D007333	24476
25149184	Association	MESH:D003924	3375
25149184	Association	OMIM:142700	24476
25149184	Association	MESH:D009765	24476
25149184	Association	MESH:D007333	3375
25149184	Association	MESH:D009461	24476
25149184	Association	MESH:D009765	3375
25149184	Association	MESH:D009461	3375
25149184	Association	MESH:D003072	3375
25149184	Association	MESH:D000090862	3375

